These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23370224)

  • 1. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer.
    Lohr M; Edlund K; Botling J; Hammad S; Hellwig B; Othman A; Berglund A; Lambe M; Holmberg L; Ekman S; Bergqvist M; Pontén F; Cadenas C; Marchan R; Hengstler JG; Rahnenführer J; Micke P
    Cancer Lett; 2013 Jun; 333(2):222-8. PubMed ID: 23370224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.
    Al-Shibli K; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    APMIS; 2010 May; 118(5):371-82. PubMed ID: 20477813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
    Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
    J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
    Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
    Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.
    Schmidt M; Hellwig B; Hammad S; Othman A; Lohr M; Chen Z; Boehm D; Gebhard S; Petry I; Lebrecht A; Cadenas C; Marchan R; Stewart JD; Solbach C; Holmberg L; Edlund K; Kultima HG; Rody A; Berglund A; Lambe M; Isaksson A; Botling J; Karn T; Müller V; Gerhold-Ay A; Cotarelo C; Sebastian M; Kronenwett R; Bojar H; Lehr HA; Sahin U; Koelbl H; Gehrmann M; Micke P; Rahnenführer J; Hengstler JG
    Clin Cancer Res; 2012 May; 18(9):2695-703. PubMed ID: 22351685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal plasma cells expressing immunoglobulin G4 subclass in non-small cell lung cancer.
    Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Koyanagi I; Aini W; Tsuruyama T; Date H; Haga H
    Hum Pathol; 2013 Aug; 44(8):1569-76. PubMed ID: 23465276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
    Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
    Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction.
    Tudor CS; Distel LV; Eckhardt J; Hartmann A; Niedobitek G; Buettner M
    Hum Pathol; 2013 Nov; 44(11):2475-86. PubMed ID: 24029709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
    Hald SM; Bremnes RM; Al-Shibli K; Al-Saad S; Andersen S; Stenvold H; Busund LT; Donnem T
    Lung Cancer; 2013 May; 80(2):209-15. PubMed ID: 23384671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.
    Kuo CS; Liu CY; Pavlidis S; Lo YL; Wang YW; Chen CH; Ko HW; Chung FT; Lin TY; Wang TY; Lee KY; Guo YK; Wang TH; Yang CT
    Front Immunol; 2018; 9():232. PubMed ID: 29483918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.
    Al-Saad S; Al-Shibli K; Donnem T; Persson M; Bremnes RM; Busund LT
    Br J Cancer; 2008 Nov; 99(9):1476-83. PubMed ID: 18854838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
    Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
    Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
    Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
    Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
    Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
    Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.